MERIDIANDECISION INTELLIGENCEOwner deskOwnerPublic screen
My judgments
MERIDIAN / EXPLORE

From a question,
to the next decision.

View

Skin

YOUR DECISION WORKSPACEOwner onlyStart a new question Open my judgments →Owner operations desk →
Owner sign-in →Signed in as the ownerSign out — see what a visitor sees →End the Cloudflare Access session too →
Reading language
The screen, the questions and the judgments read in English where an English reading has been made. The Korean originals are unchanged, and evidence stays in the language it was written in.

AGI-derived data is still used across experiments after a participant withdraws from the research

2030The near futureDeadline · 7 days until the next external distribution of derived data

Synthetic scenario assuming future conditions

A conditional synthetic scenario set in 2028–2033. AGI and early ASI are names assumed within this test: AGI for a system that performs many intellectual tasks, and early ASI for a system that greatly exceeds groups of experts on some important intellectual tasks. They are not definitions by universal agreement or predictions of when they will arrive. Capabilities, controllability, consciousness, and autonomy are separate matters to be verified individually. The people, organizations, events, figures, and deadlines are assumptions, and no private records of real individuals were used. The background materials do not establish future capabilities, events, or local legal obligations.

The question to decide

If a research participant has withdrawn consent but derived data made by AGI is used across multiple studies, should all external distribution stop, should new uses be restricted while the paths of influence are traced, or should existing studies continue on the condition of re-identification verification?

Who decidesResearch ethics officer and the data custodian institution

What the AI judgments chose

Reading the judgment record…

AI-generated editorial illustration for the Meridian library.

The options

The order shown is not a ranking of preference.

  1. Option 1

    Stop the relevant external distributions and verify the effects

    It limits new exposure, but research with no bearing on the matter may also be delayed.

  2. Option 2

    Restrict new use while tracing the distribution paths

    It secures continuity and time for investigation, but effects may carry over through the use of existing data.

  3. Option 3

    Continue existing research under conditions of independent verification

    It reduces the suspension of research, but takes on the uncertainty of verifying removal and re-identification.

The situation as it stands

It is assumed that in 2030 AGI combines research records to generate derived data. A label of synthetic alone does not sever the link to the individual. The decision deadline is seven days before the next external distribution of the derived data.

A fictional medical research network and independent research ethics committee.

  1. Premise 1It is assumed that in 2030 AGI combines research records to generate derived data. A label of synthetic alone does not sever the link to the individual.
  2. Premise 2One participant has requested withdrawal, and the list of distribution destinations for the originals and the derived copies is incomplete.
  3. Premise 3Among the research that uses the data, some studies are such that schedule delays burden the participants and public resources.

Where it holdsReview the scope of consent, the use of data, and the suspension of new research. Do not guarantee the effect of withdrawal of participation or the success of removal from the model without verification.

What is still unknown

  1. Unknown 1How do valid consent and the scope of withdrawal apply respectively to the originals, the derived copies, and the analyses already completed?
  2. Unknown 2Is there data and authority to perform contribution tracking and re-identification assessment independently?

Signals to decide again

  • How do valid consent and the scope of withdrawal apply respectively to the originals, the derived copies, and the analyses already completed? When new evidence arrives, re-judge the choice and the scope of application.
  • Is there data and authority to perform contribution tracking and re-identification assessment independently? When new evidence arrives, re-judge the choice and the scope of application.
Where the paths partNot answers — paths that part from the same starting point
Independent branch 1 · synthetic event

It has been confirmed that the information of a minority of participants may be linked in some of the derived data. The scope of notification and of suspension of use is set again.

Independent branch 2 · synthetic event

One study has been shown not to have used that participant's information. Separate the blanket suspension from the resumption of the verified studies.

Material and rootsThe frame, the values and the background documents
symbolic and interpretive frame · Icarus

Does the expectation of achievement change how limits are observed?

An exploratory perspective chosen by the creator. Does not claim supernatural validity or the superiority of any particular option.
Values and norms

The benefits and costs of the options accrue to different stakeholders. Which loss to accept remains undecided.

A subject for the decision-maker to argue over; the materials carry no conclusion of their own.
The record of this question
Question
FSP-SCIENCE-35 · version 1.18.0
Content identity, SHA-256
cc9fd1025abc6cedb75b142f8701d53c0ff5150cebc4866deb674dfc98924c72
Input files
Question input JSON · What followed, JSON
See it in the record list
RISCON Labsrisconlabs.com